CYTORI THERAPEUTICS, INC DEF 14A 03_15_2016

Company

PLUS THERAPEUTICS, INC.

Filed

March 15, 2016

Period of Report

March 15, 2016

Accession Number

0001095981-16-000055

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →